Elmind Capital »

Alector shares owned by Elmind Capital

Quarter-by-quarter ownership of Alector (ALEC) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Alector

Tip: Access up to 7 years of quarterly data

All positions including Alector held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alector by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 900k 2.15

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Alector

TCG Crossover Management
BlackRock
Vanguard Group
Acadian Asset Management
Foresite Capital Management IV
Vanguard Capital Management
Merck & Co
D. E. Shaw & Co
683 Capital Management
Balyasny Asset Management
Nantahala Capital Management
Vanguard Portfolio Management
Geode Capital Management
FMR
Jacobs Levy Equity Management

View all funds holding Alector